E
Rapid Dose Therapeutics Corp.
RDTCF
$0.18
$0.0320.00%
E
Sell
8/15/2024Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 8/15/2024 due to a noticeable decline in the growth index and solvency index. The quick ratio declined from 0.13 to 0.12.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 8/15/2024 due to a noticeable decline in the growth index and solvency index. The quick ratio declined from 0.13 to 0.12.
D
Sell
4/29/2024Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 4/29/2024 due to an increase in the volatility index.
E
Sell
4/12/2024Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 4/12/2024 due to a substantial decline in the valuation index, volatility index and solvency index. The quick ratio declined from 0.08 to 0.06, and debt to equity increased from -0.68 to -0.66.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 4/12/2024 due to a substantial decline in the valuation index, volatility index and solvency index. The quick ratio declined from 0.08 to 0.06, and debt to equity increased from -0.68 to -0.66.
D
Sell
4/26/2023Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 4/26/2023 due to an increase in the volatility index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 4/26/2023 due to an increase in the volatility index.
E
Sell
3/14/2023Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 03/14/2023.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 2/23/2023 due to a substantial increase in the valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 2/23/2023 due to a substantial increase in the valuation index.
E
Sell
2/8/2023Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from -1.74 to -1.34.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index, solvency index and total return index. Debt to equity increased from -1.74 to -1.34.
D
Sell
1/30/2023Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to D- from D on 1/30/2023 due to a significant decline in the solvency index, total return index and growth index. Operating cash flow declined 111.21% from -$92.8 to -$196, total revenue declined 92.63% from $659.5 to $48.6, and the quick ratio declined from 0.09 to 0.05.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to D- from D on 1/30/2023 due to a significant decline in the solvency index, total return index and growth index. Operating cash flow declined 111.21% from -$92.8 to -$196, total revenue declined 92.63% from $659.5 to $48.6, and the quick ratio declined from 0.09 to 0.05.
D
Sell
5/16/2022Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 5/16/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/13/2022Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 5/13/2022 due to a decline in the volatility index and total return index.
D
Sell
5/4/2022Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 5/4/2022 due to an increase in the volatility index and valuation index.
E
Sell
5/1/2022Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 5/1/2022 due to a decline in the volatility index and total return index.
D
Sell
4/21/2022Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 4/21/2022 due to an increase in the volatility index.
E
Sell
4/20/2022Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index and total return index.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 4/20/2022 due to a decline in the volatility index and total return index.
D
Sell
11/9/2021Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from E+ on 11/9/2021 due to an increase in the valuation index.
E
Sell
11/8/2021Downgrade
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index and growth index. Earnings per share declined from $0.0013 to -$0.0049.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E+ from D on 11/8/2021 due to a decline in the valuation index and growth index. Earnings per share declined from $0.0013 to -$0.0049.
D
Sell
12/1/2020Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from D- on 12/1/2020 due to a major increase in the growth index, valuation index and volatility index. Total revenue increased 92.86% from $1.4 to $2.7.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D from D- on 12/1/2020 due to a major increase in the growth index, valuation index and volatility index. Total revenue increased 92.86% from $1.4 to $2.7.
D
Sell
10/5/2020Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 10/5/2020 due to an increase in the volatility index and total return index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to D- from E+ on 10/5/2020 due to an increase in the volatility index and total return index.
E
Sell
8/3/2020Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to E+ from E on 8/3/2020 due to an increase in the solvency index and valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to E+ from E on 8/3/2020 due to an increase in the solvency index and valuation index.
E
Sell
5/1/2020Upgraded
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to E from E- on 5/1/2020 due to an increase in the valuation index.
Rapid Dose Therapeutics Corp. (RDTCF) was upgraded to E from E- on 5/1/2020 due to an increase in the valuation index.
E
Sell
2/25/2020None
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E- from U on 02/25/2020.
Rapid Dose Therapeutics Corp. (RDTCF) was downgraded to E- from U on 02/25/2020.
OTC PK
12/27/2024 10:15AM Eastern
Quotes delayed
